Pfizer Korea appealed administrative judgment, for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ to the original state

Pfizer Korea appealed administrative judgment to Anti-Corruption and Civil Rights Commission for the purpose of returning the price of neuropathic pain treatment ‘Lyrica’ (pregabalin) to the original state.

Pfizer Korea won a patent suit against domestic pharamaceutical company which produces generic drug of Lyrica, and protected Lyrica's indication for neuropathic pain treatment. The problem ...